Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

70.97 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
60 61 Next >
2 Top Stocks to Buy Near Their 52-Week Lows
They are down but not out. 
Via The Motley Fool
3 S&P 500 Stocks to Sell Before a Crash
Here's a list of S&P 500 stocks to sell. Each has a unique reason behind its bearish thesis, prompting investors to take action. 
Via InvestorPlace
Topics Stocks
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now 
Via Benzinga
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This?
Health insurers dramatically mark up prices of generics and pharmacies are in on the scheme. 
Via Talk Markets
Looking Into CVS Health's Recent Short Interest
 
Via Benzinga
Amazon Stock ‘Has Something For Everyone’ - Gina Sanchez
Via Talk Markets
11 Analysts Have This to Say About CVS Health
 
Via Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
CVS, Walgreens Boots Among Firms Receiving Warning Letter Against Selling Unapproved Eye Products
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating fed 
Via Benzinga
It's a Good Time To Buy High-Yield Dogs of the Dividend Kings
These Dividend Kings have been hammered for the last year but now offer value and high yield with a chance for a significant share price rebound. 
Via MarketBeat
S&P 500: Tesla, Apple Chipmaker Lead Big Movers
Aerospace giant RTX led losers on the benchmark index Monday. 
Via Investor's Business Daily
Topics Stocks
Check Out What Whales Are Doing With CVS
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has  
Via Benzinga
Walmart Contemplates Multi-billion Dollar Majority Stake In ChenMed
Walmart Inc. (NYSE: WMT) is reportedly contemplating the  
Via Benzinga
The 3 Best Safe Stocks to Buy Now: September 2023
Buying safe stocks despite the market looking healthy is a wise investment decision because there are still signs a recession could occur. 
Via InvestorPlace
Topics Economy
If You'd Invested $25,000 in CVS Health 20 Years Ago, This Is How Much You Would Have Today
Your investment grew nicely, but would investing in CVS have been a better move than simply going with the S&P 500? 
Via The Motley Fool
Topics Stocks
3 Dow Stocks to Sell in September Before They Crash and Burn
Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell. 
Via InvestorPlace
Topics Stocks
2 Underappreciated Dividend Stocks to Buy in September and Hold Forever
After falling significantly in recent weeks, these excellent dividend stocks look like screaming buys. 
Via The Motley Fool
Could CVS Make a Copy of Ozempic?
Given its new biosimilars unit, copying Ozempic is more likely than it sounds. 
Via The Motley Fool
MarketBeat Week in Review – 8/28 - 9/1
The markets ended the week with mixed results as stocks enter what is historically the toughest month of the year and next week volume should pick up 
Via MarketBeat
Topics Economy
CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know
CVS just fired a shot across Viatris' bow. 
Via The Motley Fool
CVS Just Made a Major New Announcement, But Should You Buy It?
Spinning up a new division will probably be a boon for shareholders. 
Via The Motley Fool
Is Federal Realty Investment Trust a Buy?
It's a great company, but the yield is nothing special. 
Via The Motley Fool
3 Undervalued Healthcare Stocks In 2023
These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential. 
Via Talk Markets
Now or Never: 7 Blue-Chip Stocks Offering a Once-in-a-Lifetime Opportunity
If you're looking for a once-in-a-lifetime investment opportunity, consider these seven blue-chip stocks to buy now. 
Via InvestorPlace
Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?
These two high-potential healthcare names bring a rare opportunity for investors to gain some exposure to quality businesses trading at a discount to industry 
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS